drugset / Trial / NCT06193148
A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the effect of Jaktinib Hydrochloride Tablets on QT/QTc interval in healthy subjects after a single oral administration.
Timeline
- Start
- 2024-03-19
- Primary completion
- 2024-06-18
- Completion
- 2024-06-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Jaktinib | Unknown | 100 mg | Oral |
| Subject | Jaktinib | Unknown | 400 mg | Oral |
| Subject | Jaktinib | Unknown | 600 mg | Oral |
| Subject | Jaktinib | Unknown | 800 mg | Oral |
Indications
No indication recorded.